~ The largest ever MedTech private financing round worldwide ~
London, 29 June 2021, Consilium Strategic Communications (Consilium), a global leader in strategic healthcare communications and investor relations, is pleased to have supported CMR Surgical on the communication of its $600 million (£425 million) Series D financing. The round was led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group and supported by other new international and existing investors.
CMR works with surgeons and hospitals to provide an optimal tool to make robotic keyhole surgery universally accessible and affordable. Versius’ size, portability and versatility have made it very popular with hospitals and surgeons around the world. As part of CMR’s ongoing international expansion, Versius has been successfully launched in multiple geographies worldwide including across Europe, Australia, India and the Middle East. Global demand for CMR’s surgical robot continues to grow with significant further momentum anticipated.
“It is fantastic to see a fundraise of this magnitude which is testament to not only the overall excellence of Versius, but to the whole team at CMR. We have a long-standing relationship with the company and have enjoyed watching it evolve into one of the world’s most disruptive medical devices company.”
Mary-Jane Elliott
Managing Partner at Consilium Strategic Communications
“This latest fundraise, the largest ever MedTech private financing round worldwide, equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide. Thank you to the professional team at Consilium for their strategic advice as we have communicated this news globally. We are looking forward to continuing our close relationship with Consilium as we execute our business strategy.”
Per Vegard Nerseth
Chief Executive Officer of CMR
The funds raised will be used to rapidly accelerate CMR’s geographical expansion and builds upon the framework the company has established to grow a long-term independent global business. The new funds will also support the continued development of the system’s digital framework, including new technological developments such as Versius Connect, an app for surgeons using the Versius surgical robotic system.
The Consilium team was led by Mary-Jane Elliott and supported by Angela Gray, Lindsey Neville and Alexander Bridge. J.P. Morgan acted as sole placement agent on CMR Surgical’s Series D financing.
To view CMR’s announcement, please click here.
